12 new BIRD projects ready to fly

By Ora Coren

The BIRD Foundation (Israel-United States Binational Industrial Research and Development Foundation) board of trustees approved 12 new projects last week. They are worth a total of $34 million, out of which BIRD will finance $10 million.

The foundation approved three life sciences projects - Proneuron Biotechnologies, an Israeli company, and Craig Hospital in the United States in the field of spinal cord injury therapies; Glycominds of Israel and the German-American company Schott Glass Technologies who are cooperating on developing a chip to diagnose genetic illnesses; Notel Vision of Israel and the Zeiss-Humphrey Systems are developing a diagnostic device for the eye disease Age Related Macular Degeneration.

The electro-optic projects approved were joint projects between Terra-Op of Israel and TranSwitch and between GalayOr Networks of Israel and Analog Devices. The joint software projects approved were between Cardonet DSO of Israel and Cayenta and between the Israel company CareerHarmony and the American company Manpower.